Sol-Gel Technologies Ltd. (SLGL)
$69.50+1.76%Close
BUYCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $227M
- Beta
- 1.15
- P/E (TTM)
- -12.32
- Short % float
- 17.09%
- Days to cover
- 3.0
- SI change
- +19.3%
- 1W
- -3.39%
- 1M
- +7.92%
- vs SPY 1W
- -3.25%
- vs SPY 1M
- +5.41%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 5
- GROWTH
- 19
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-26.4%
REV YoY-
ROE-44.1%
EPS YoY-
ROA-30.4%
GROSS100
OP-987
NET-910
[VALUATION]
P/E TTM-12.32
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B4.73
P/FCF-
EV/EBITDA-12.18
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.60
ALTMAN Z-
CURR RATIO10.37
ND/EBITDA-
BETA1.15
Company news
FAQ
- What is LOPJLB’s current signal on SLGL?
- LOPJLB’s latest quantitative signal on Sol-Gel Technologies Ltd. (SLGL) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is SLGL in?
- Sol-Gel Technologies Ltd. (SLGL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Sol-Gel Technologies Ltd. (SLGL) do?
- Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyne…